Avacta, Cytiva make progress on Covid-19 rapid test development
Biotherapeutics and reagents developer Avacta said the first rapid test strips to detect SARS-COV-2 spike protein had been developed and evaluated by partner Cytiva.
The...
Wed, 24/06/2020 - 13:29